Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.08 billion.

GUIDANCE:

Pfizer sees FY2017 EPS of $2.54-$2.60, versus the consensus of $2.55. Pfizer sees FY2017 revenue of $52-54 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.